Press Releases

Official running program of Memorial Sloan Kettering Cancer Center sets new single-year fundraising record with every dollar raised going directly to cancer research.

Memorial Sloan Kettering Cancer Center (MSK) has welcomed Whitney Snider, MD, MBA, as the inaugural Managing Partner of MSK Ventures – a dedicated investment pool that will raise and direct funds to high-growth, early-stage startups created and/or nurtured by MSK faculty and staff.

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Jason Lewis Elected as a Fellow of the National Acad...

Deb Schrag, MD, MPH, FASCO, gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), has been elected 2027-28 President of the American Society of Clinical Oncology (ASCO), the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

Official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center to host its stationary-cycling events in 16 locations nationwide. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the high-energy rides.

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI), a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society.

Researchers from Memorial Sloan Kettering Cancer Center (MSK) announced today that the latest results from that follicular lymphoma clinical trial have shown the three-drug combination — rituximab (Rituxan®) and lenalidomide (Revlimid®), along with epcoritamab (Epkinly®) — works better than using the two drugs alone. The findings were presented at the American Society of Hematology Annual Meeting (ASH) on December 7, 2025. The findings were also published in The Lancet.

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Omar Abdel-Wahab Elected to the National Academy of ...

Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.